This inventor holds 1 USPTO granted patent. Top assignees: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences Pla China, Zhejiang Xianju Pharmaceuticals Co. Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Yongshao Liu: Innovator in Pharmaceutical Chemistry
Introduction
Yongshao Liu is a talented inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on oripavine derivatives. His research has implications for developing novel pharmaceuticals, showcasing the potential of his innovative spirit and expertise.
Latest Patents
Yongshao Liu holds a patent that focuses on oripavine derivatives and their uses as pharmaceuticals. This patent involves the formulation of oripavine derivatives of formula (I), aimed at enhancing therapeutic efficacy. By exploring these chemical compounds, Liu's work could pave the way for new treatment options in medicine.
Career Highlights
Throughout his career, Yongshao Liu has worked at notable institutions, including the Institute of Pharmacology and Toxicology Academy of Military Medical Sciences PLA China and Zhejiang Xianju Pharmaceuticals Co., Ltd. These positions reflect his dedication to advancing research in pharmacology and toxicology, fostering innovation in the pharmaceutical industry.
Collaborations
Yongshao Liu has collaborated with several esteemed colleagues, including Bohua Zhong and Zehui Gong. Together, they have contributed to various research projects that aim to enhance understanding and application of pharmaceutical compounds.
Conclusion
Yongshao Liu exemplifies the qualities of an innovative inventor in the pharmaceutical landscape. His patent on oripavine derivatives highlights his commitment to advancing medical science and improving health outcomes. With his collaborations and career experience, he remains a vital contributor to the field of pharmacology and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile